Academy of Continued Healthcare Learning, ProPatient, and ArcheMedX Extend Collaboration to Improve Shared Decision Making in Patient Care
Charlottesville, VA, May 23, 2017 (Newswire) –The Academy of Continued Healthcare Learning (ACHL), ProPatient, and ArcheMedX have launched a series of integrated online learning programs that have successfully educated and empowered both healthcare providers and patients/caregivers to share decision making in addressing the challenges of treating Idiopathic Pulmonary Fibrosis (IPF) and Non-Small Cell Lung Cancer (NSCLC).
As scientific discoveries accelerate and our healthcare system becomes more complex, it is critical for clinicians and patients to communicate and collaborate to optimize patient-centric care. While the benefits of shared decision making are well established, it is far from the norm and significant efforts are need to ensure that all stakeholders are comfortable, capable, and committed.
“Online learning is a cost-effective way to provide physicians with on-demand access to the latest clinical advances and a trusted channel to educate and empower patients to participate in their care,” said Lisa Keckich, Executive Director at ACHL. She added, “ACHL entered into this partnership to assess whether an integrated educational approach would facilitate shared decision making for complex diseases like IPF and lung cancer. The success of these initiatives demonstrates the power of the ArcheMedX and ProPatient platforms to educate and motivate clinicians and patients to work collaboratively and has established a model we eagerly anticipate extending to additional clinical areas.”
Through these interventions clinicians are better prepared to guide their patients through a shared decision making process and patients are better informed and more empowered to participate in their care.
Improving Engagement with IPF Patients
Since launching in December 2016, more than a thousand clinicians and patients have participated in the educational program, enhancing multidisciplinary approaches to care and addressing the unique and evolving needs of patients with IPF.
80% of clinicians engaged by the program reported making changes to their shared decision-making practices since participating. Furthermore, 85% of IPF patients reported that the patient education activity helped them better understand IPF.(Insert one line with patient data/results)
You can learn more about this IPF program here.
Improving Engagement with Lung Cancer Patients
Since launching in June 2016, thousands of lung cancer clinicians and patients have participated in the educational program, enhancing personalized approaches to care and simplifying important challenges related to diagnosis and treatment.
90% of clinicians engaged by the program reported that they had increased the frequency in which they engage their patients with NSCLC in shared decision-making since participating. 58% of patients feel that they learned from the activity and were better able to understand their diagnosis.(Insert one line with patient data/results)
You can learn more about this NSCLC program here.
*These interventions would not be possible without commercial support. The IPF program is supported by an educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, Inc. and the NSCLC program is supported by an educational grant from Genentech, Inc.
ACHL is an-award winning provider of continuing medical education programs. Its mission is to design, develop, and implement quality continuing education activities that have a positive influence on the way healthcare is practiced and ultimately, to improve the quality of care provided to patients.
ProPatient is a patient-focused, online educational platform that utilizes interactive video and engaging simulation to provide patients with the opportunity to ask questions of a virtual clinician and role-play different scenarios to improve their skills.
ArcheMedX is a healthcare informatics and e-learning technology company that is transforming online education through a data-driven approach to learning. By leveraging nearly five decades of cognitive science and years of applied research, the ArcheMedX team has developed an award-winning e-learning and analytics platform that simplifies the design, delivery, and analysis of online education and training across the healthcare industry.
ArcheMedX currently partners with dozens of healthcare organizations (national medical societies, leading academic medical centers, major pharmaceutical firms, and global medical education companies) to power and analyze hundreds of more engaging and interactive learning experiences available across dozens of clinical and non-clinical areas. Learners who participate in ArcheMedX-powered education have been found to improve their knowledge and competence at a level four-to-six times greater than traditional online education. To learn more, visit www.archemedx.com.